Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,601 signal articles · 135 in last 24h · 155,365 total before filter · latest 2h ago
135last 24h
852last 7d
146● bullish (7d)
90● bearish (7d)
214publishers
AllMacro192Earnings102M&A125Regulatory20Product22Analyst19
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
MACOM (MTSI): Buy, Sell, or Hold Post Q2 Earnings?
StockStory41d agoneutral
MACOM (MTSI): Buy, Sell, or Hold Post Q2 Earnings?

MACOM currently trades at $308.10 and has been a dream stock for shareholders. It’s returned 404% since August 2021, blowing past the S&P 500’s 72.8% gain. The company has also beaten the index over the past six months as its stock price is up 26.2% thanks to its solid quarterly results.

Figs (FIGS): Buy, Sell, or Hold Post Q2 Earnings?
StockStory41d agoneutral
Figs (FIGS): Buy, Sell, or Hold Post Q2 Earnings?

What a fantastic six months it’s been for Figs. Shares of the company have skyrocketed 42.2%, hitting $14.58. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Is Iovance Biotherapeutics (IOVA) Undervalued As Q2 Earnings Reaffirm Revenue Guidance?
Simply Wall St.41d agoneutral
Is Iovance Biotherapeutics (IOVA) Undervalued As Q2 Earnings Reaffirm Revenue Guidance?

Why Iovance Biotherapeutics stock is back in focus after Q2 earnings Iovance Biotherapeutics (IOVA) is back on investor radars after its second quarter 2026 earnings. The company reported higher revenue and a reduced net loss, and it reaffirmed full year revenue guidance. The quarter was driven by Amtagvi and Proleukin sales, and by progress across Iovance Biotherapeutics pipeline programs, including new regulatory approvals and Fast Track designations for lifileucel in certain soft tissue...

Is QXO (QXO) Undervalued Following Earnings And The TopBuild Acquisition?
Simply Wall St.41d agoneutral
Is QXO (QXO) Undervalued Following Earnings And The TopBuild Acquisition?

QXO earnings and recent performance QXO (QXO) reported second quarter 2026 results on August 13, with sales of US$3.25b and a net loss of US$55m. Six month sales reached US$4.98b, with a net loss of US$282m. See our latest analysis for QXO. QXO's share price has come under pressure despite the recent earnings report and the completion of the TopBuild acquisition, with the stock down 10% over the past week and recording a 26% year to date share price decline and a 5 year total shareholder...

5 Must-Read Analyst Questions From Unity’s Q2 Earnings Call
StockStory41d agoneutral
5 Must-Read Analyst Questions From Unity’s Q2 Earnings Call

Unity’s second quarter results were marked by robust revenue growth and significant margin improvement, triggering a notable positive market response. Management cited the rapid adoption of its Vector AI-powered ad platform and a suite of product enhancements as primary drivers of performance. CEO Matthew Bromberg emphasized the impact of integrating runtime data and noted, “Our astounding performance is fueling a 63% year-over-year increase in our Strategic Grow business.” The company’s renewed

nCino (NCNO): Buy, Sell, or Hold Post Q1 Earnings?
StockStory42d agoneutral
nCino (NCNO): Buy, Sell, or Hold Post Q1 Earnings?

nCino has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.4%. The stock now trades at $19.16, marking a 20.9% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Sidus Space Q2 Earnings Call Highlights
MarketBeat42d agoneutral
Sidus Space Q2 Earnings Call Highlights

Sidus Space (NASDAQ:SIDU) reported lower second-quarter revenue while strengthening its cash position through two equity offerings that generated $158.5 million in gross proceeds during the quarter. Management said the company is shifting its focus from technology demonstrations toward customer adop

Earnings Prove AI Hardware Demand Is Strong. That’s Good News for Dell Stock.
Barrons.com42d agoneutral
Earnings Prove AI Hardware Demand Is Strong. That’s Good News for Dell Stock.

Dell Technologies stock could have more room to run—even after this year’s meteoric rise—as artificial intelligence hardware demand remains resilient. Wells Fargo analyst Aaron Rakers raised his price target on Dell to $545 from $505 on Friday, which implies a 10% increase from the stock’s last closing price of $494.51. Dell’s “server results and outlook present continued upside,” Rakers wrote in a research note.